These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 9036064)
1. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva]. Römisch M; Meier W; Kimmig R; Hepp H Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha]. Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix. Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672 [TBL] [Abstract][Full Text] [Related]
4. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495 [TBL] [Abstract][Full Text] [Related]
5. Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer. Song M; DiPaola RS; Cracchiolo BM; Gibbon DG; Hellmann M; Nieves-Neira W; Vaidya A; Wagreich AR; Shih WJ; Rodriguez-Rodriguez L Int J Gynecol Cancer; 2014 Nov; 24(9):1636-41. PubMed ID: 25304678 [TBL] [Abstract][Full Text] [Related]
6. Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project. Carson LF; Twiggs LB; Adcock LL; Prem KA; Potish RA J Reprod Med; 1990 Nov; 35(11):1029-32. PubMed ID: 2277364 [TBL] [Abstract][Full Text] [Related]
7. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085 [TBL] [Abstract][Full Text] [Related]
8. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Lupi G; Raspagliesi F; Zucali R; Fontanelli R; Paladini D; Kenda R; di Re F Cancer; 1996 Apr; 77(8):1472-8. PubMed ID: 8608531 [TBL] [Abstract][Full Text] [Related]
9. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236 [TBL] [Abstract][Full Text] [Related]
10. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008 [TBL] [Abstract][Full Text] [Related]
11. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials. Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030 [TBL] [Abstract][Full Text] [Related]
12. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Eisenhauer EA; Lippman SM; Kavanagh JJ; Parades-Espinoza M; Arnold A; Hong WK; Massimini G; Schleuniger U; Bollag W; Holdener EE Leukemia; 1994 Oct; 8(10):1622-5. PubMed ID: 7934156 [TBL] [Abstract][Full Text] [Related]
13. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084 [TBL] [Abstract][Full Text] [Related]
14. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Piura B; Masotina A; Murdoch J; Lopes A; Morgan P; Monaghan J Gynecol Oncol; 1993 Feb; 48(2):189-95. PubMed ID: 8428690 [TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study. Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056 [TBL] [Abstract][Full Text] [Related]
16. Groin recurrence in carcinoma of the vulva: management and outcome. Cormio G; Loizzi V; Carriero C; Cazzolla A; Putignano G; Selvaggi L Eur J Cancer Care (Engl); 2010 May; 19(3):302-7. PubMed ID: 19832900 [TBL] [Abstract][Full Text] [Related]
17. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon. Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263 [TBL] [Abstract][Full Text] [Related]
18. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers. Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438 [TBL] [Abstract][Full Text] [Related]
19. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study. Nikolaou AC; Fountzilas G; Daniilidis I J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297 [TBL] [Abstract][Full Text] [Related]
20. Midline involvement as a risk factor for vulvar cancer recurrence. Stankevica J; Macuks R; Baidekalna I; Donina S Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]